We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+5.08%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$836M
AUM Growth
+$186M
Cap. Flow
+$173M
Cap. Flow %
20.65%
Top 10 Hldgs %
29.89%
Holding
597
New
223
Increased
13
Reduced
17
Closed
170

Top Buys

Rank Stock Value
1
ATIP
ATI Physical Therapy, Inc.
ATIP
+$22.4M
2
AVAH icon
Aveanna Healthcare
AVAH
+$20.8M
3
AGTI
Agiliti Inc
AGTI
+$16.7M
4
GENI icon
Genius Sports
GENI
+$16M
5
MYPS icon
PLAYSTUDIOS Inc
MYPS
+$14.5M

Top Sells

Rank Stock Value
1
BEAM icon
Beam Therapeutics
BEAM
+$13.5M
2
SHC icon
Sotera Health
SHC
+$8.74M
3
PSFE icon
Paysafe
PSFE
+$8.13M
4
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$6.83M
5
HQY icon
HealthEquity
HQY
+$6.8M

Sector Composition

Rank Sector Weight
1 Healthcare 33.03%
2 Financials 12.76%
3 Technology 11.06%
4 Industrials 8.14%
5 Communication Services 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABCL icon
76
AbCellera Biologics
ABCL
$2.12B
$2.97M 0.36%
+135,000
New +$3.72M
TBPH icon
77
Theravance Biopharma
TBPH
$877M
$2.9M 0.35%
+200,000
New +$3.76M
TMAC
78
DELISTED
The Music Acquisition Corporation
TMAC
$2.9M 0.35%
+299,996
New +$2.93M
CNTA
79
DELISTED
Centessa Pharmaceuticals
CNTA
$2.89M 0.35%
+130,000
New +$3.06M
SOFI icon
80
SoFi Technologies
SOFI
$23.7B
$2.88M 0.34%
+150,000
New +$2.78M
MDVL
81
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
$2.82M 0.34%
4,611
– –
GLUE icon
82
Monte Rosa Therapeutics
GLUE
$1.35B
$2.72M 0.33%
+120,000
New +$2.44M
AVTR icon
83
Avantor
AVTR
$9.19B
$2.66M 0.32%
+75,000
New +$2.43M
CELH icon
84
Celsius Holdings
CELH
$7.03B
$2.66M 0.32%
+105,000
New +$2.14M
PARA
85
DELISTED
Paramount Global Class B
PARA
$2.65M 0.32%
58,600
-71,400
-55% -$2.95M
AEVA
86
Aeva Technologies
AEVA
$1.86B
$2.64M 0.32%
50,000
– –
LYEL icon
87
Lyell Immunopharma
LYEL
$360M
$2.6M 0.31%
+8,000
New +$2.62M
MREO
88
Mereo BioPharma
MREO
$47.3M
$2.54M 0.3%
800,000
-200,000
-20% -$671K
JAMF
89
DELISTED
Jamf
JAMF
$2.52M 0.3%
+75,000
New +$2.55M
LVOX
90
DELISTED
LiveVox Holding, Inc. Class A Common Stock
LVOX
$2.5M 0.3%
+300,000
New +$2.96M
GMBT
91
DELISTED
Pivotal Holdings Corp Class A Ordinary Share
GMBT
$2.5M 0.3%
+250,000
New +$2.44M
AI icon
92
C3.ai
AI
$1.59B
$2.5M 0.3%
+40,000
New +$2.49M
OMEG
93
DELISTED
Omega Alpha SPAC Class A Ordinary Shares
OMEG
$2.49M 0.3%
250,000
– –
INSM icon
94
Insmed
INSM
$28.6B
$2.48M 0.3%
+87,000
New +$2.58M
HCAQ
95
DELISTED
HealthCor Catalio Acquisition Corp. Class A Ordinary Shares
HCAQ
$2.46M 0.29%
250,000
– –
IMPX
96
DELISTED
AEA-Bridges Impact Corp
IMPX
$2.44M 0.29%
250,000
– –
UHG
97
DELISTED
United Homes Group
UHG
$2.42M 0.29%
+249,992
New +$2.44M
CFIV
98
DELISTED
CF Acquisition Corp. IV Class A common stock
CFIV
$2.42M 0.29%
250,000
– –
CMBM
99
DELISTED
Cambium Networks
CMBM
$2.42M 0.29%
+50,000
New +$2.67M
HCCC
100
DELISTED
Healthcare Capital Corp. Class A common stock
HCCC
$2.41M 0.29%
250,000
– –
2 3
4
5 6

Similar funds

SWMG
Sard Wealth Management Group Atlanta, Georgia $184M AUM 11.26% 1-Year Est. Return
IFPL
Investments & Financial Planning LLC Lexington, Kentucky $184M AUM 17.7% 1-Year Est. Return
RFG
RFP Financial Group Atlanta, Georgia $184M AUM 16.06% 1-Year Est. Return
NAM
Nutshell Asset Management Sevenoaks, United Kingdom $184M AUM 2.02% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return
GCA
GSI Capital Advisors Newport Beach, California $184M AUM 5.17% 1-Year Est. Return
IVGAV
Index Venture Growth Associates V St. Helier, Jersey $184M AUM

Monashee Investment Management's Q2 2021 Portfolio in Review

As of Q2 2021, Monashee Investment Management held 597 positions worth $836M, up 29% from $650M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Monashee Investment Management deployed $173M of net new capital in Q2 2021, opening 223 new positions and adding to 13 existing holdings. Its largest new stake was ATI Physical Therapy, Inc.: 45,248 shares worth $21.6M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 27% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Beam Therapeutics, an estimated $13.5M trimmed.

  • Monashee Investment Management's largest Q2 2021 buy was ATI Physical Therapy, Inc.: 45,248 shares worth $21.6M.
  • Monashee Investment Management added most to PLAYSTUDIOS Inc in Q2 2021, an estimated $14.5M increase.
  • Monashee Investment Management's biggest Q2 2021 reduction was Beam Therapeutics, cutting an estimated $13.5M.
  • Monashee Investment Management fully exited Sotera Health in Q2 2021, selling an estimated $8.74M.
  • Monashee Investment Management's ten largest holdings make up 30% of its $836M portfolio in Q2 2021.
  • Monashee Investment Management opened 223 new positions and closed 170 in Q2 2021.
  • Monashee Investment Management's portfolio value rose 29% quarter-over-quarter to $836M.

Based on Monashee Investment Management's 13F filing for Q2 2021, filed 12 Aug 2021.